Healthcare Services

Blood screening market insights highlighting growth opportunities

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Blood Screening Market Progress Between 2026 And 2030?

The blood screening market has witnessed substantial growth over recent years. Its size is projected to expand from $3.44 billion in 2025 to $3.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. The market’s historical growth can be attributed to several factors, including more stringent regulatory screening requirements, an increase in blood donation volumes, the rising prevalence of transfusion-transmitted infections, the development of centralized blood banks, and the adoption of ELISA-based testing.

The blood screening market is anticipated to experience substantial growth over the next few years. It is projected to reach $5.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.5%. This expansion during the forecast period can be attributed to factors such as increased investments in advanced screening technologies, a rising demand for rapid and accurate diagnostics, the broadening adoption of molecular testing, the increasing integration of AI-driven data analysis, and a heightened focus on global blood safety standards. Prominent trends for the forecast period include the growing uptake of nucleic acid testing technologies, an escalating demand for high-throughput screening systems, the expanding utilization of automated blood screening instruments, the proliferation of software-integrated screening platforms, and an intensified emphasis on transfusion safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Which Important Drivers Are Guiding The Blood Screening Market Growth?

The rising incidence of chronic diseases is anticipated to drive the expansion of the blood screening market. These are long-lasting medical conditions or illnesses that, while often manageable, lack a cure and necessitate adaptation to ongoing treatment and its requirements. Blood screening plays a crucial role in ensuring compatibility between donor and recipient blood types during transfusion procedures. Such transfusions are frequently essential in managing various chronic conditions, including autoimmune disorders, blood-related diseases, and diverse forms of cancer. A notable example is the statistic from September 2023, where the World Health Organization, a specialized UN agency located in Switzerland, reported 41 million deaths globally each year attributable to non-communicable diseases (NCDs) or chronic diseases, accounting for 74% of total deaths. Consequently, the growing occurrence of chronic diseases is a significant catalyst for the growth of the blood screening market.

How Is The Blood Screening Market Segmented Across Different Segment Categories?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

What Trends Are Influencing The Evolution Of The Blood Screening Market?

Key players in the blood screening market are advancing technologies like liquid biopsy to enhance the early detection of cancer, improve how treatments are monitored, and enable individualized medicine approaches. A liquid biopsy is a minimally invasive procedure that scrutinizes blood or other bodily fluids to identify cancer cells or tumor-derived genetic material. For instance, in November 2023, Guardant Health, Inc., a US-based biotechnology company, launched its Shield blood-based screening tests. The Shield test analyzes cell-free DNA (cfDNA) present in the bloodstream, which can indicate colorectal tumors or precancerous growths. It specifically searches for changes in DNA fragments that cancer cells release into the blood.

Which Organizations Play A Role In The Blood Screening Market Landscape?

Major companies operating in the blood screening market are Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Cepheid Inc., Haemonetics Corporation, Verax Biomedical Inc.

Get The Full Blood Screening Market Report:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Which Region Has The Greatest Market Share In The Blood Screening Market?

North America was the largest region in the blood screening market in 2025. The regions covered in the blood screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Blood Screening Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Browse Through More Reports Similar to the Global Blood Screening Market 2026, By The Business Research Company

Bleeding Disorder Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

Drug Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Blood Culture Tests Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795